Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer

Molecular Cancer Therapeutics

Volumn 10, Issue 4, 2011, Pages 637-647

  Sher, Yuh Pyng ^a,b   Liu, Shih Jen ^b,c   Chang, Chun Mien ^a   Lien, Shu Pei ^c   Chen, Chien Hua ^a   Han, Zhenbo ^d   Li, Long Yuan ^a,b   Chen, Jin Shing ^e   Wu, Cheng Wen ^f   Hung, Mien Chie ^a,b,d,g  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROTEIN VP16; SURVIVIN; TRANSCRIPTION FACTOR GAL4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIKDD GENE; CANCER GENE THERAPY; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LUNG CANCER; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; CYTOKINES; FEMALE; GENE THERAPY; GENETIC VECTORS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; MUTANT PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR BURDEN;

EID: 79955763145     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0827     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Gunther M, Wagner E, Ogris M. Specific targets in tumor tissue for the delivery of therapeutic genes. Curr Med Chem Anticancer Agents 2005;5:157-71. (Pubitemid 40347989)
3. Chen JS, Liu JC, Shen L, Rau KM, Kuo HP, Li YM, et al. Cancerspecific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther 2004;11:740-7. (Pubitemid 39488472)
4. Xie X, Xia W, Li Z, Kuo HP, Liu Y, Li Z, et al. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Cancer Cell 2007;12:52-65. (Pubitemid 47001785)
5. Sher YP, Tzeng TF, Kan SF, Hsu J, Xie X, Han Z, et al. Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival. Oncogene 2009;28:3286-95.
6. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003;3:46-54. (Pubitemid 37328886)
7. Li F, Ling X. Survivin study: an update of "what is the next wave"? J Cell Physiol 2006;208:476-86.
8. Zaffaroni N, Pennati M, Daidone MG. Survivin as a target for new anticancer interventions. J Cell Mol Med 2005;9:360-72.
9. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008;14:5000-5.
10. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell 17:53-64.
11. Lin KY, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI, August JT, Pardoll DM, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996;56:21-6. (Pubitemid 26010379)
12. Ji H, Chang EY, Lin KY, Kurman RJ, Pardoll DM, Wu TC. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer 1998;78:41-5. (Pubitemid 28391672)
13. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997;15:647-52. (Pubitemid 27291165)
14. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, et al. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 2008;68:7428-38.
15. Chen HW, Leng CH, Liu HY, Cheng WF, Chang YW, Wu PY, et al. Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization. Cancer Biol Ther 2009;8:2025-32.
16. Chen W, Huang L. Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine. Mol Pharm 2008;5:464-71. (Pubitemid 351929830)
17. Hofmann UB, Voigt H, Andersen MH, Straten PT, Becker JC, Eggert AO. Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes. Eur J Immunol 2009;39:1419-24.
18. Sim SH, Liu Y, Wang D, Novem V, Sivalingam SP, Thong TW, et al. Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection. PLoS One 2009;4:e7308.
19. Lipke AB, Matute-Bello G, Herrero R, Kurahashi K, Wong VA, Mongovin SM, et al. Febrile-range hyperthermia augments lipopolysaccharide-induced lung injury by a mechanism of enhanced alveolar epithelial apoptosis. J Immunol 2010;184:3801-13.
20. Li YM, Wen Y, Zhou BP, Kuo HP, Ding Q, Hung MC. Enhancement of Bik antitumor effect by Bik mutants. Cancer Res 2003;63:7630-3. (Pubitemid 37466686)
21. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997;8:803-15. (Pubitemid 27231908)
22. Cayeux S, Richter G, Noffz G, Dorken B, Blankenstein T. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J Immunol 1997;158:2834-41. (Pubitemid 127470543)
23. McArthur JG, Mulligan RC. Induction of protective anti-tumor immunity by gene-modified dendritic cells. J Immunother 1998;21:41-7. (Pubitemid 28044835)
24. Stripecke R, Carmen Villacres M, Skelton D, Satake N, Halene S, Kohn D. Immune response to green fluorescent protein: implications for gene therapy. Gene Ther 1999;6:1305-12. (Pubitemid 29359025)
25. Lanuti M, Rudginsky S, Force SD, Lambright ES, Siders WM, Chang MY, et al. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. Cancer Res 2000;60:2955-63. (Pubitemid 30395821)
26. Walker WE, Booth CJ, Goldstein DR. TLR9 and IRF3 cooperate to induce a systemic inflammatory response in mice injected with liposome: DNA. Mol Ther 2010;18:775-84.
27. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000;191:423-34.
28. Yrlid U, Wick MJ. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med 2000;191:613-24.
29. Feng H, Zeng Y, Whitesell L, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood 2001;97:3505-12.